LyondellBasell
LYB NYSE Specialty Chemicals Financials FY2016βFY2025
LyondellBasell's revenue fell 9.7% to $30.2 billion in fiscal 2025. Its operating margin was β1.4%, down from 5.7% a year earlier. Free cash flow was $384 million, down 80.6%. It paid out $2.0 billion in dividends and buybacks, 512% of free cash flow.
About these figures. LyondellBasell's filings don't tag its average share count, so share counts and the measures built on them are blank.
What LyondellBasell does
No business description yet.
- Legal name
- LYONDELLBASELL INDUSTRIES N.V.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001489393-26-000012
0001489393
Revenue and margins
LyondellBasell had $30.2B of revenue in fiscal 2025, down 9.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $384M in fiscal 2025, 1.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
LyondellBasell returned $2.0B to shareholders in fiscal 2025, 512% of free cash flow. The diluted share count rose 0.0%.
Value LyondellBasell yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$7.5B and divides by 0.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Balance sheet
Cash, debt and the ratios that show how comfortably LyondellBasell can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.5B | $2.2B | $5.8B | $6.0B | $5.5B |
| Debt incl. finance leases | $11.6B | $11.3B | $11.2B | $11.1B | $12.9B |
| Net debt / EBITDA | 1.2x | 1.4x | 1.3x | 1.5x | 7.7x |
| Debt / equity | 1.0x | 0.9x | 0.9x | 0.9x | 1.3x |
| Interest coverage | 13.1x | 17.8x | 5.7x | 4.0x | β0.9x |
| Current ratio | 1.7x | 1.8x | 1.8x | 1.8x | 1.8x |
| Quick ratio | 1.0x | 1.0x | 1.2x | 1.1x | 1.2x |
| Total assets | $36.7B | $36.4B | $37.0B | $35.7B | $34.0B |
| Total liabilities | $24.9B | $23.7B | $24.1B | $23.3B | $23.9B |
| Shareholders' equity | $11.9B | $12.6B | $12.9B | $12.5B | $10.1B |
| Net debt (β = net cash) | $10.1B | $9.2B | $5.4B | $5.2B | $7.5B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.2M
1 insider
Sold, 12 months
$27.0M
2 insiders
Of sales under plans
0%
$0.0M
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β7.7% | β6.7% | β8.6% |
| Altman Z'' | 2.98 | 2.79 | 1.93 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| LyondellBasell LYB | β | β9.7% | β1.4% | 1.3% | β1.9% | β | β | |
| Sherwin-Williams SHW | $82.9B | 2.1% | β | 11.3% | 19.9% | 31.1x | 6 | Compare β |
| Ecolab ECL | $81.4B | 2.2% | 17.0% | 11.8% | 13.8% | 38.7x | 5 | Compare β |
| PPG Industries PPG | $24.8B | 0.2% | β | 7.3% | 14.4% | 15.8x | 7 | Compare β |
| Westlake WLK | $8.3B | β8.0% | β14.1% | β4.7% | β10.0% | β | 3 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $29.2B | $34.5B | $39.0B | $34.7B | $27.8B | $46.2B | $50.5B | $33.3B | $33.4B | $30.2B |
| Gross profit | $6.0B | $6.4B | $6.5B | $5.4B | $3.4B | $8.8B | $6.6B | $4.9B | $4.6B | $2.6B |
| Research and development | $99.0M | $106M | $115M | $111M | $113M | $124M | $124M | $130M | $135M | $136M |
| Operating income | $5.1B | $5.5B | $5.2B | $4.1B | $1.6B | $6.8B | $5.1B | $2.7B | $1.9B | β$420M |
| Interest expense | $322M | $491M | $360M | $347M | $526M | $519M | $287M | $477M | $481M | $487M |
| Pretax income | $5.2B | $5.5B | $5.3B | $4.1B | $1.4B | $6.8B | $4.8B | $2.3B | $1.7B | β$715M |
| Income tax | $1.4B | $598M | $613M | $648M | β$43.0M | $1.2B | $882M | $433M | $259M | $70.0M |
| Net income | $3.8B | $4.9B | $4.7B | $3.4B | $1.4B | $5.6B | $3.9B | $2.1B | $1.4B | β$738M |
| Diluted EPS | $9.13 | $12.23 | $12.01 | $9.58 | $4.24 | $16.75 | $11.81 | $6.46 | $4.15 | β$2.34 |
| Cash flow | ||||||||||
| Cash from operations | $5.6B | $5.2B | $5.5B | $5.0B | $3.4B | $7.7B | $6.1B | $4.9B | $3.8B | $2.3B |
| Capital expenditure | $2.2B | $1.5B | $2.1B | $2.7B | $1.9B | $2.0B | $1.9B | $1.5B | $1.8B | $1.9B |
| Free cash flow | $3.4B | $3.7B | $3.4B | $2.3B | $1.5B | $5.7B | $4.2B | $3.4B | $2.0B | $384M |
| Depreciation and amortization | $1.1B | $1.2B | $1.2B | $1.3B | $1.4B | $1.4B | $1.3B | $1.5B | $1.5B | $1.4B |
| Stock-based compensation | $38.0M | $55.0M | $39.0M | $48.0M | $55.0M | $66.0M | $70.0M | $91.0M | $91.0M | $91.0M |
| Acquisitions | $0.0M | $0.0M | $1.8B | $0.0M | $0.0M | $106M | $4.0M | $102M | $0.0M | $0.0M |
| Share buybacks | $2.9B | $866M | $1.9B | $3.8B | $4.0M | $463M | $420M | $211M | $195M | $201M |
| Dividends paid | $1.4B | $1.4B | $1.6B | $1.5B | $1.4B | $1.5B | $3.2B | $1.6B | $1.7B | $1.8B |
| Dividends and buybacks | $4.3B | $2.3B | $3.4B | $5.2B | $1.4B | $1.9B | $3.7B | $1.8B | $1.9B | $2.0B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $2.0B | $2.8B | $1.2B | $1.1B | $2.5B | $1.5B | $2.2B | $5.8B | $6.0B | $5.5B |
| Total debt | $9.0B | $8.6B | $9.4B | $12.1B | $16.0B | $11.6B | $11.3B | $11.2B | $11.1B | $12.9B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $9.6B | $11.7B | $10.6B | $9.5B | $11.6B | $12.2B | $11.8B | $13.2B | $12.3B | $10.9B |
| Current liabilities | $4.5B | $4.8B | $5.5B | $5.2B | $5.5B | $7.2B | $6.8B | $7.2B | $6.7B | $6.1B |
| Inventory | $3.8B | $4.2B | $4.5B | $4.6B | $4.3B | $4.9B | $4.8B | $4.8B | $4.7B | $3.5B |
| Property and equipment, net | $10.1B | $11.0B | $12.5B | $14.1B | $14.4B | $14.6B | $15.4B | $15.5B | $15.1B | $15.8B |
| Total assets | $23.4B | $26.2B | $28.3B | $30.4B | $35.4B | $36.7B | $36.4B | $37.0B | $35.7B | $34.0B |
| Total liabilities | $17.4B | $17.3B | $18.0B | $22.4B | $27.4B | $24.9B | $23.7B | $24.1B | $23.3B | $23.9B |
| Shareholders' equity | $6.0B | $8.9B | $10.3B | $8.0B | $8.0B | $11.9B | $12.6B | $12.9B | $12.5B | $10.1B |
| Margins | ||||||||||
| Gross margin | 20.5% | 18.6% | 16.6% | 15.6% | 12.2% | 19.0% | 13.1% | 14.7% | 13.9% | 8.6% |
| Operating margin | 17.3% | 15.8% | 13.4% | 11.9% | 5.6% | 14.7% | 10.1% | 8.2% | 5.7% | β1.4% |
| EBITDA margin | 21.0% | 19.2% | 16.6% | 15.6% | 10.6% | 17.7% | 12.6% | 12.8% | 10.3% | 3.2% |
| Net margin | 13.1% | 14.2% | 12.0% | 9.8% | 5.1% | 12.2% | 7.7% | 6.4% | 4.1% | β2.5% |
| FCF margin | 11.5% | 10.6% | 8.6% | 6.5% | 5.3% | 12.4% | 8.4% | 10.2% | 5.9% | 1.3% |
| Returns | ||||||||||
| Return on capital | 29.0% | 35.0% | 27.9% | 18.4% | 7.7% | 25.8% | 19.0% | 11.0% | 9.0% | β1.9% |
| Return on capital employed | 27.1% | 27.1% | 23.7% | 17.2% | 5.7% | 22.8% | 17.3% | 9.2% | 6.5% | β1.5% |
| Return on equity | 60.9% | 65.1% | 48.8% | 37.1% | 17.8% | 56.7% | 31.8% | 16.6% | 10.8% | β6.6% |
| Return on assets | 16.6% | 19.7% | 17.2% | 11.6% | 4.3% | 15.6% | 10.6% | 5.8% | 3.8% | β2.1% |
| Growth | ||||||||||
| Revenue growth | β10.9% | 18.2% | 13.1% | β11.0% | β20.1% | 66.4% | 9.3% | β33.9% | 0.2% | β9.7% |
| Net income growth | β14.3% | 27.2% | β3.9% | β27.6% | β58.0% | 293.6% | β30.8% | β45.5% | β35.6% | β154.0% |
| EPS growth | β4.8% | 34.0% | β1.8% | β20.2% | β55.7% | 295.1% | β29.5% | β45.3% | β35.8% | β156.4% |
| FCF growth | β23.6% | 8.8% | β8.0% | β32.7% | β35.7% | 293.7% | β26.3% | β19.3% | β42.0% | β80.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.1x | 0.9x | 1.3x | 2.0x | 4.6x | 1.2x | 1.4x | 1.3x | 1.5x | 7.7x |
| Debt / equity | 1.5x | 1.0x | 0.9x | 1.5x | 2.0x | 1.0x | 0.9x | 0.9x | 0.9x | 1.3x |
| Interest coverage | 15.7x | 11.1x | 14.5x | 11.9x | 3.0x | 13.1x | 17.8x | 5.7x | 4.0x | β0.9x |
| Current ratio | 2.1x | 2.5x | 1.9x | 1.8x | 2.1x | 1.7x | 1.8x | 1.8x | 1.8x | 1.8x |
| Quick ratio | 1.3x | 1.6x | 1.1x | 1.0x | 1.3x | 1.0x | 1.0x | 1.2x | 1.1x | 1.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 7.7% | 4.5% | 5.4% | 7.8% | 7.0% | 4.2% | 3.8% | 4.6% | 5.5% | 6.2% |
| Stock comp / revenue | 0.1% | 0.2% | 0.1% | 0.1% | 0.2% | 0.1% | 0.1% | 0.3% | 0.3% | 0.3% |
| Payouts / FCF | 128.8% | 62.3% | 101.3% | 230.0% | 96.7% | 34.0% | 86.7% | 53.4% | 96.7% | 511.7% |
| Quality scores | ||||||||||
| Altman Z'' | 4.9 | 5.7 | 3.8 | 2.7 | 2.2 | 3.4 | 3.2 | 3.0 | 2.8 | 1.9 |
| Accruals ratio | β7.7% | β1.3% | β2.9% | β5.3% | β6.0% | β5.8% | β6.1% | β7.7% | β6.7% | β8.6% |
Source: SEC EDGAR XBRL filings (CIK 0001489393). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.